Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiwerth

Showing results (281-290 of 321) with videos related to

Pageof 33
Sort By:
Current Pharmaceutical Design|June 9, 2018
Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract HealingPredrag Sikiric, Rudolf Rucman, Branko Turkovic, et al.
Frontiers in Pharmacology|February 7, 2022
Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in RatsMarijan Tepes, Slaven Gojkovic, Ivan Krezic, et al.
Journal of Physiology, Paris|May 3, 2000
Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157P Sikiric, J Separovic, G Buljat, et al.
Acta Pharmacologica Sinica|April 30, 2002
Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbancesPredrag Sikiric, Nikola Jelovac, Andjelka Jelovac-Gjeldum, et al.
European Journal of Pharmacology|July 30, 1997
The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressureP Sikirić, S Seiwerth, Z Grabarević, et al.
Current Neuropharmacology|March 15, 2026
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection ApproachIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Current Neuropharmacology|January 27, 2025
Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in RatsIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Frontiers in Pharmacology|December 30, 2021
Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in RatsMarijan Tepes, Slaven Gojkovic, Ivan Krezic, et al.
Pageof 33

Showing results (281-290 of 321) with videos related to

Sort By:
Pageof 33
Current Pharmaceutical Design|June 9, 2018
Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract HealingPredrag Sikiric, Rudolf Rucman, Branko Turkovic, et al.
Frontiers in Pharmacology|February 7, 2022
Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in RatsMarijan Tepes, Slaven Gojkovic, Ivan Krezic, et al.
Journal of Physiology, Paris|May 3, 2000
Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157P Sikiric, J Separovic, G Buljat, et al.
Acta Pharmacologica Sinica|April 30, 2002
Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbancesPredrag Sikiric, Nikola Jelovac, Andjelka Jelovac-Gjeldum, et al.
European Journal of Pharmacology|July 30, 1997
The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressureP Sikirić, S Seiwerth, Z Grabarević, et al.
Current Neuropharmacology|March 15, 2026
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection ApproachIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Current Neuropharmacology|January 27, 2025
Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in RatsIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Frontiers in Pharmacology|December 30, 2021
Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in RatsMarijan Tepes, Slaven Gojkovic, Ivan Krezic, et al.
Pageof 33